These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19124429)

  • 1. Prehypertension: should we be treating with pharmacologic therapy?
    Egan BM; Nesbitt SD; Julius S
    Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):305-14. PubMed ID: 19124429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it time to treat prehypertension?
    Papadopoulos DP; Makris TK; Papademetriou V
    Hypertens Res; 2008 Sep; 31(9):1681-6. PubMed ID: 18971545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehypertension: an opportunity for a new public health paradigm.
    Egan BM; Lackland DT; Jones DW
    Cardiol Clin; 2010 Nov; 28(4):561-9. PubMed ID: 20937441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prehypertension: risk stratification and management considerations.
    Egan BM; Julius S
    Curr Hypertens Rep; 2008 Oct; 10(5):359-66. PubMed ID: 18775112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prehypertension: the rationale for early drug therapy.
    Fuchs FD
    Cardiovasc Ther; 2010 Dec; 28(6):339-43. PubMed ID: 20553286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive drugs in diabetic's hypertension].
    Pugliese F
    G Ital Nefrol; 2006; 23 Suppl 34():S26-31. PubMed ID: 16633991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehypertension - time to act.
    Gupta P; Nagaraju SP; Gupta A; Mandya Chikkalingaiah KB
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):223-33. PubMed ID: 22382212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating prehypertension: medically sound and economically viable.
    Kiely AE; Kwatra SG; Kwatra MM
    Blood Press; 2009; 18(6):300-3. PubMed ID: 19958077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for prehypertension.
    Nesbitt SD
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):250-5. PubMed ID: 17420669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prehypertension and risk of cardiovascular disease.
    Atilla K; Vasan RS
    Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):111-7. PubMed ID: 16375633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study.
    Nesbitt SD; Julius S; Leonard D; Egan BM; Grozinski M;
    Am J Hypertens; 2005 Jul; 18(7):980-5. PubMed ID: 16053996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure lowering only or more? Has the jury reached its verdict?
    Julius S
    Am J Cardiol; 2007 Aug; 100(3A):32J-37J. PubMed ID: 17666196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons in hypertension from new clinical trials.
    Nesbitt SD
    Postgrad Med; 2009 Nov; 121(6):34-43. PubMed ID: 19940415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.
    Gaddam KK; Ventura H; Lavie CJ
    Future Cardiol; 2012 Jan; 8(1):115-22. PubMed ID: 22185450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
    Armario P; de la Sierra A
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):197-204. PubMed ID: 19443514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension treatment guidelines: practical implications.
    Choi KL; Bakris GL
    Semin Nephrol; 2005 Jul; 25(4):198-209. PubMed ID: 16202692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.